
£1.4m prostate cancer study aims to predict which tumours spread
At a glance
- The research will combine MRI scans, blood and urine tests, biopsy samples and genetic information.
- It focuses on assessing risk after a prostate cancer diagnosis.
- Prostate Cancer UK and the John Black Charitable Foundation are funding the project.
- Researchers hope the findings could help some men avoid unnecessary procedures and treatment.
A £1.4 million study led by King's College London will use data from more than 1,000 men with prostate cancer to develop computer models that could help doctors predict which tumours will grow or spread.
The project, called ReIMAGINE[Life], aims to give patients and doctors more certainty when deciding whether to begin treatment or monitor a cancer. UCL also reported on the research on 13 November.
A clearer picture from existing tests
Doctors currently rely heavily on examining biopsy samples (small samples of tissue) under a microscope to judge how aggressive a cancer may be. But those samples provide only part of the information available about a patient's disease.
The researchers will bring together findings from scans, laboratory tests and genetic data, then link them with NHS records to follow what happens to patients over time. They will train computer models to look for patterns that could help predict a cancer's behaviour from diagnosis.
Professor Mieke Van Hemelrijck, Professor in Cancer Epidemiology (the study of how cancer affects groups of people) at King's, is leading the project with colleagues at UCL, Imperial College London and Radboud University in the Netherlands.
She said: "One of the biggest ongoing challenges in prostate cancer is that we still can't reliably predict which cancers will become life-threatening and which will remain low risk."
Why it matters
That uncertainty leaves doctors and patients facing difficult choices. Some men may undergo procedures or treatment they do not need, while others need their cancer identified as aggressive and treated sooner.
Dr Matthew Hobbs, Director of Research at Prostate Cancer UK, said: "Getting a more accurate picture of each man's cancer means more men getting the right treatment at the right time, fewer men experiencing unnecessary side effects, and ultimately more lives saved."
The team still needs to develop the proposed tool. If successful, it could help doctors make those decisions with greater confidence.
Living with uncertainty
For Barry O'Carroll, 54, from Cheshire, the hardest part was knowing he had cancer without knowing whether it would spread. He said it was not clear at first how aggressive it would be.
Doctors told him it might be five, 10 or even 15 years before his cancer changed, but that they would monitor him closely through active surveillance. When it began growing nine months later, the change was detected and he had surgery. He said the operation was successful and he is now cancer-free.
He has no regrets about his treatment, but believes knowing more about his cancer's likely behaviour would have made the experience easier.
What this means for you
- If you are on active surveillance: the NHS explains that this involves regular tests and scans in hospital. If you have concerns, speak to your care team. You do not need to wait for your next check-up.
- If you are worried about symptoms or your risk: speak to a GP. Urinary changes do not always mean cancer, but symptoms that change, get worse or do not feel normal should be checked. Prostate cancer can also have no symptoms at first.
- For a routine appointment about these concerns: you can book a GP appointment through myGP where your practice offers online booking. Contact your practice directly if you cannot find a suitable appointment.
- To learn more about the project: King's is holding an online launch event on Thursday 10 December, 5pm to 6pm. Details are on the King's College London news page.
For more health guides, see myGP Learn.
Sources: King's College London, King's awarded £1.4m to develop next-generation prostate cancer tool; UCL, Computer models help spot life-threatening prostate cancer, 13 November 2026; NHS, Prostate cancer: treatment and symptoms.
